The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
TSH-Controlled L-Thyroxine Therapy Reduces Cholesterol Levels and Clinical Symptoms in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Trial (Basel Thyroid Study)
Open accessAbstract
This study evaluated the effect of physiological, TSH-guided, L-thyroxine treatment on serum lipids and clinical symptoms in patients with subclinical hypothyroidism. Sixty-six women with proven subclinical hypothyroidism (TSH, 11.7 +/- 0.8 mIU/liter) were randomly assigned to receive L-thyroxine or placebo for 48 wk. Individual L-thyroxine replacement (mean dose, 85.5 +/- 4.3 microg/d) was performed based on blinded TSH monitoring, resulting in euthyroid TSH levels (3.1 +/- 0.3 mIU/liter). Lipid concentrations and clinical scores were measured before and after treatment. Sixty-three of 66 patients completed the study. In the L-thyroxine group (n = 31) total cholesterol and low density lipoprotein cholesterol were significantly reduced [-0.24 mmol/liter, 3.8% (P = 0.015) and -0.33 mmol/liter, 8.2% (P = 0.004), respectively]. Low density lipoprotein cholesterol decrease was more pronounced in patients with TSH levels greater than 12 mIU/liter or elevated low density lipoprotein cholesterol levels at baseline. A significant decrease in apolipoprotein B-100 concentrations was observed (P = 0.037), whereas high density lipoprotein cholesterol, triglycerides, apolipoprotein AI, and lipoprotein(a) levels remained unchanged. Two clinical scores assessing symptoms and signs of hypothyroidism (Billewicz and Zulewski scores) improved significantly (P = 0.02). This is the first double blind study to show that physiological L-thyroxine replacement in patients with subclinical hypothyroidism has a beneficial effect on low density lipoprotein cholesterol levels and clinical symptoms of hypothyroidism. An important risk reduction of cardiovascular mortality of 9-31% can be estimated from the observed improvement in low density lipoprotein cholesterol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
TUNBRIDGE, W. M. G., EVERED, D. C., HALL, R., APPLETON, D., BREWIS, M., CLARK, F., EVANS, J. G., YOUNG, E., BIRD, T., & SMITH, P. A. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,674
The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey
Vanderpump, M. P. J., Tunbrldge, W. M. G., French, J. M., Appleton, D., Bates, D., Clark, F., Evans, J. G., Hasan, D. M., Rodgers, H., Tunbridge, F., et al. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01894.x · Cited by 2,432
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Hak, A. E., Pols, H. A. P., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00004 · Cited by 1,336
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259 · cited 1×
“It has been shown that endogenous SCH may be associated with adverse effects, such as mild clinical signs of hyperthyroidism and impaired quality of life (46), induction of atrial fibrillation (47), acceleration of osteoporosis, or possibly dementia and Alzheimer’s disease (48).”
BackgroundAmerican Thyroid Association Guidelines for Detection of Thyroid Dysfunction
Ladenson, P. W., Singer, P. A., Ain, K. B., Bagchi, N., Bigos, S. T., Levy, E. G., Smith, S. A., & Daniels, G. H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.11.1573 · Cited by 575
Verschuren, W. M. M. (1995) · JAMA · doi:10.1001/jama.1995.03530020049031 · Cited by 573
Cooper, D. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450406 · Cited by 528
Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism
Singer, P. A. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520340064038 · Cited by 427
Danese, M. D. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.2993 · Cited by 424
L-Thyroxine Therapy in Subclinical Hypothyroidism: A Double-Blind, Placebo-Controlled Trial
COOPER, D. S., HALPERN, R., WOOD, L. C., LEVIN, A. A., & RIDGWAY, E. C. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-18 · Cited by 423
Biondi, B. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4701 · Cited by 356
Zulewski, H., Müller, B., Exer, P., Miserez, A. R., & Staub, J.-J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3810 · Cited by 338
Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study
Kalmijn, S., Mehta, K. M., Pols, H. A. P., Hofman, A., Drexhage, H. A., & Breteler, M. M. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01146.x · Cited by 320
Staub, J.-J., Althaus, B. U., Engler, H., Ryff, A. S., Trabucco, P., Marquardt, K., Burckhardt, D., Girard, J., & Weintraub, B. D. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90782-7 · Cited by 318
NYSTRÖM, E., CAIDAHL, K., FAGER, G., WIKKELSÖ, C., LUNDBERG, P. ‐., & LINDSTEDT, G. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb00250.x · Cited by 309
Monzani, F., Di Bello, V., Caraccio, N., Bertini, A., Giorgi, D., Giusti, C., & Ferrannini, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7291 · Cited by 308
Screening for Thyroid Disease: An Update
Helfand, M., & Redfern, C. C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00020 · Cited by 304
LDL/HDL‐CHANGES IN SUBCLINICAL HYPOTHYROIDISM: POSSIBLE RISK FACTORS FOR CORONARY HEART DISEASE
ALTHAUS, B. U., STAUB, J. ‐., LÈCHE, A. R., OBERHÄNSLI, A., & STÄHELIN, H. B. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03651.x · Cited by 246
SINGER, P. A. (1995) · JAMA · doi:10.1001/jama.273.10.808 · Cited by 235
Jaeschke, R., Guyatt, G., Gerstein, H., Patterson, C., Molloy, W., Cook, D., Harper, S., Griffith, L., & Carbotte, R. (1996) · Journal of General Internal Medicine · doi:10.1007/bf02598988 · Cited by 216
Subclinical hypothyroidism: a modifiable risk factor for depression?
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.3.508 · Cited by 214
Zulewski, H. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.3.771 · Cited by 211
Subclinical hypothyroidism: neurobehavioral features and beneficial effect of l-thyroxine treatment
Monzanil, F., Guerra, P., Caracciol, N., Pruneti, C. A., Puccil, E., Luisit, M., & Baschieri, L. (1993) · The Clinical Investigator · doi:10.1007/bf00186625 · Cited by 203
Danese, M. D. (1996) · JAMA · doi:10.1001/jama.1996.03540040029029 · Cited by 194
Surks, M. I., & Ocampo, E. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89462-4 · Cited by 193
Spectrum of Pituitary Alteration with Mild and Severe Thyroid Impairment* †
BIGOS, S. T., RIDGWAY, E. C., KOURIDES, I. A., & MALOOF, F. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-2-317 · Cited by 185
Tanis, B. C., Westendorp, R. G. J., & Smelt, A. H. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.739560.x · Cited by 177 · cited 1×
“Conversely, our data are in accordance with 2 recent meta-analyses that calculated a beneficial effect of l-thyroxine on serum cholesterol concentrations (29, 34).”
ResultTUNBRIDGE, W. M. G., EVERED, D. C., HALL, R., APPLETON, D., BREWIS, M., CLARK, F., EVANS, J. G., YOUNG, E., BIRD, T., & SMITH, P. A. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01341.x · Cited by 177
The Aging Thyroid: Increased Prevalence of Elevated Serum Thyrotropin Levels in the Elderly
Sawin, C. T. (1979) · JAMA · doi:10.1001/jama.1979.03300030019013 · Cited by 176
Obesity, mortality and cardiovascular disease in the Münster Heart Study (PROCAM)
Schulte, H., Cullen, P., & Assmann, G. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00055-6 · Cited by 175
Prevalence and Correction of Hypothyroidism in a Large Cohort of Patients Referred for Dyslipidemia
Diekman, T. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.14.1490 · Cited by 168
Impaired Action of Thyroid Hormone Associated with Smoking in Women with Hypothyroidism
Müller, B., Zulewski, H., Huber, P., Ratcliffe, J. G., & Staub, J.-J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331503 · Cited by 167
PRECLINICAL HYPOTHYROIDISM: A RISK FACTOR FOR CORONARY HEART-DISEASE*1
Bastenie, P. A., Vanhaelst, L., Bonnyns, M., Neve, P., & Staquet, M. (1971) · The Lancet · doi:10.1016/s0140-6736(71)90947-0 · Cited by 163
Michalopoulou, G., Alevizaki, M., Piperingos, G. D., Mitsibounas, D. N., Mantzos, E., Adamopoulos, P., & Koutras, D. A. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380141 · Cited by 156
Lipoprotein and Apolipoprotein Levels in Subclinical Hypothyroidism: Effect of Levothyroxine Therapy
Arem, R., & Patsch, W. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.10.2097 · Cited by 151
DECREASED HDL CHOLESTEROL IN SUBCLINICAL HYPOTHYROIDISM: THE EFFECT OF L‐THYROXINE THERAPY
CARON, P., Calazel, C., Parra, H. J., Hoff, M., & Louvet, J. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03889.x · Cited by 143
Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease
Müller, B., Tsakiris, D. A., Roth, C. B., Guglielmetti, M., Staub, J. ‐., & Marbet, G. A. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00777.x · Cited by 136
Self-citationRidgway, E. C., Cooper, D. S., Walker, H. J., Rodbard, D., & Maloof, F. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-6-1238 · Cited by 131
Thyroxine replacement therapy and circulating lipid concentrations
Franklyn, J. A., Daykin, J., Betteridge, J., Hughes, E. A., Holder, R. L., Jones, S. R., & Sheppard, M. C. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00339.x · Cited by 102
Subclinical Thyroid Disease: A Clinician's Perspective
Cooper, D. S. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00016 · Cited by 102
Arem, R., Rokey, R., Kiefe, C. I., Escalante, D. A., & Rodríguez, A. (1996) · Thyroid · doi:10.1089/thy.1996.6.397 · Cited by 85
Lipoprotein(a) Concentration in Subclinical Hypothyroidism Before and After Levo-Thyroxine Therapy.
Yıldırımkaya, M., Özata, M., YILMAZ, K., Kılınç, C., Gündoğan, M. A., & Kutluay, T. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.731 · Cited by 81
Arem, R., Escalante, D. A., Arem, N., Morrisett, J. D., & Patsch, W. (1995) · Metabolism · doi:10.1016/0026-0495(95)90075-6 · Cited by 79
Danese, M. D. (1996) · JAMA · doi:10.1001/jama.276.4.285 · Cited by 68
Bogner, U., Arntz, H.-R., Peters, H., & Schleusener, H. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1280202 · Cited by 63
SYMPTOMLESS AUTOIMMUNE THYROIDITIS IN CORONARY HEART-DISEASE
Heinonen, O. P., Aho, K., Pyörälà, K., Gordin, A., Punsar, S., & Puro, K. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90534-x · Cited by 59
Cooper, D. S. (2013) · Thyroid Research and Practice · doi:10.4103/0973-0354.106807 · Cited by 54
Sellitti, D. F., Dennison, D., Akamizu, T., Doi, S. Q., Kohn, L. D., & Koshiyama, H. (2000) · Thyroid · doi:10.1089/thy.2000.10.219 · Cited by 53
The systolic time intervals in thyroid dysfunction
BURCKHARDT, D., Staub, J.-J., Kraenzlin, M., Raeder, E. A., Engel, U. R., & Cloppenburg, P. (1978) · American Heart Journal · doi:10.1016/0002-8703(78)90462-3 · Cited by 37
Ooi, T. C., Whitlock, R. M. L., Frengley, P. A., & Ibbertson, H. K. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb03431.x · Cited by 32
Elte, J.-W., Mudde, A. H., & Kruseman, A. C. N. (1996) · Postgraduate Medical Journal · doi:10.1136/pgmj.72.845.141 · Cited by 24
Cited by
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
“Doses of 25–75 lg daily are usually sufficient for achieving euthyroid levels (160), with larger doses usually required for those presenting with higher TSH values (161).”
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
Metadata
- Authors
- Meier, C.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-10-01
- Volume
- 86
- Issue
- 10
- Pages
- 4860-4866
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2085556990
- Cited by
- 401
- References
- 53
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.